Literature DB >> 23562103

Tissue distribution of enrofloxacin in African clawed frogs (Xenopus laevis) after intramuscular and subcutaneous administration.

Stephen Felt1, Mark G Papich, Antwain Howard, Tyler Long, Gabriel McKeon, Stéphanie Torreilles, Sherril Green.   

Abstract

As part of an enrofloxacin pharmacokinetic study, concentrations of enrofloxacin and ciprofloxacin (metabolite) were measured in various tissues (brain, heart, kidney, liver, lung, and spleen) collected from treated (subcutaneous delivery, n = 3; intramuscular delivery, n = 3; untreated controls, n = 2) adult female Xenopus laevis by using HPLC. Enrofloxacin was rapidly absorbed after administration by either route and readily diffused into all sampled tissues. Enrofloxacin and ciprofloxacin were present in the tissue samples collected at 8 h. The highest average tissue concentrations for enrofloxacin were found in kidney, with the lowest concentrations in liver. Ciprofloxacin tissue concentrations paralleled but were always lower than those of enrofloxacin for all time points and tissues except brain and kidney. These results, together with previously published pharmacokinetic data and known minimal inhibitory concentrations of common pathogenic bacteria, provide a strong evidence-based rationale for choosing enrofloxacin to treat infectious diseases in X. laevis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23562103      PMCID: PMC3624788     

Source DB:  PubMed          Journal:  J Am Assoc Lab Anim Sci        ISSN: 1559-6109            Impact factor:   1.232


  10 in total

Review 1.  Rational dosing of antibiotics: the use of plasma concentrations versus tissue concentrations.

Authors:  Ping Liu; Markus Müller; Hartmut Derendorf
Journal:  Int J Antimicrob Agents       Date:  2002-04       Impact factor: 5.283

2.  Standardization of a broth microdilution susceptibility testing method to determine minimum inhibitory concentrations of aquatic bacteria.

Authors:  R A Miller; R D Walker; J Carson; M Coles; R Coyne; I Dalsgaard; C Gieseker; H M Hsu; J J Mathers; M Papapetropoulou; B Petty; C Teitzel; R Reimschuessel
Journal:  Dis Aquat Organ       Date:  2005-05-20       Impact factor: 1.802

Review 3.  Tissue concentrations: do we ever learn?

Authors:  Johan W Mouton; Ursula Theuretzbacher; William A Craig; Paul M Tulkens; Hartmut Derendorf; Otto Cars
Journal:  J Antimicrob Chemother       Date:  2007-12-06       Impact factor: 5.790

4.  The pharmacokinetics of enrofloxacin in adult African clawed frogs (Xenopus laevis).

Authors:  Antwain M Howard; Mark G Papich; Stephen A Felt; Charles T Long; Gabriel P McKeon; Emmitt S Bond; Stéphanie L Torreilles; Richard H Luong; Sherril L Green
Journal:  J Am Assoc Lab Anim Sci       Date:  2010-11       Impact factor: 1.232

5.  Antimicrobial susceptibility of bacterial isolates from sea otters (Enhydra lutris).

Authors:  Deborah Brownstein; Melissa A Miller; Stori C Oates; Barbara A Byrne; Spencer Jang; Michael J Murray; Verena A Gill; David A Jessup
Journal:  J Wildl Dis       Date:  2011-04       Impact factor: 1.535

6.  In vitro killing of Escherichia coli, Staphylococcus pseudintermedius and Pseudomonas aeruginosa by enrofloxacin in combination with its active metabolite ciprofloxacin using clinically relevant drug concentrations in the dog and cat.

Authors:  J M Blondeau; S Borsos; L D Blondeau; B J Blondeau
Journal:  Vet Microbiol       Date:  2011-08-22       Impact factor: 3.293

7.  Distribution of enrofloxacin in intestinal tissue and contents of healthy pigs after oral and intramuscular administrations.

Authors:  C Wiuff; J Lykkesfeldt; F M Aarestrup; O Svendsen
Journal:  J Vet Pharmacol Ther       Date:  2002-10       Impact factor: 1.786

8.  Mechanisms of quinolone resistance and clonal relationship among Aeromonas salmonicida strains isolated from reared fish with furunculosis.

Authors:  Etienne Giraud; Guillaume Blanc; Agnes Bouju-Albert; François-Xavier Weill; Claire Donnay-Moreno
Journal:  J Med Microbiol       Date:  2004-09       Impact factor: 2.472

9.  Comparative quantification of the in vitro activity of veterinary fluoroquinolones.

Authors:  M Grobbel; A Lübke-Becker; L H Wieler; R Froyman; S Friederichs; S Filios
Journal:  Vet Microbiol       Date:  2007-03-27       Impact factor: 3.293

10.  Accumulation and killing kinetics of fifteen quinolones for Escherichia coli, Staphylococcus aureus and Pseudomonas aeruginosa.

Authors:  A E Asuquo; L J Piddock
Journal:  J Antimicrob Chemother       Date:  1993-06       Impact factor: 5.790

  10 in total
  1 in total

1.  Efficacy of enrofloxacin in a mouse model of sepsis.

Authors:  Andrea R Slate; Sheila Bandyopadhyay; Kevin P Francis; Mark G Papich; Brian Karolewski; Eldad A Hod; Kevin A Prestia
Journal:  J Am Assoc Lab Anim Sci       Date:  2014-07       Impact factor: 1.232

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.